CraigJHoesleyMD

Infectious Disease • Birmingham, AL

Professor, Medicine, University of Alabama School of Medicine

Join to view full profile

Dr. Hoesley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoesley's full profile

Already have an account?

Office
1717 6th Ave S
Birmingham, AL 35233
Phone+1 800-822-8816

Summary

Director of Internal Medicine Clerkships

Education & Training

University of Alabama Medical CenterFellowship, Infectious Disease, 1996 - 1999
University of Alabama Medical CenterResidency, Internal Medicine, 1992 - 1996
University of South Florida College of MedicineClass of 1992

Certifications & Licensure

AL State Medical License 1993 - 2025
American Board of Internal Medicine Infectious Disease

Clinical Trials

Safety and Acceptability of a Vaginal Microbicide
Completed
Phase 2
Rectal Safety and Acceptability Study of Tenofovir 1% Gel Start of enrollment: 2010 Oct 01
Completed
Phase 1
Safety and Adherence of a Non-medicated Intravaginal Ring (IVR) Start of enrollment: 2011 May 01
Completed
Phase 2
Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring Start of enrollment: 2011 Nov 01
Completed
Phase 1
Study of Dapivirine Vaginal Ring (VR) in Adolescents Start of enrollment: 2014 Jun 27
Completed
Phase 2
Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use Start of enrollment: 2014 May 01
Completed
Phase 1
Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women Start of enrollment: 2016 Feb 01
Join now to see all

Publications & Presentations

PubMed

A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.
Sharon A Riddler, Clifton W Kelly, Craig J Hoesley, Ken S Ho, Jeanna M Piper
The Journal of Infectious Diseases. 2024-09-23
1 citations
History of Rectal Product Use and Country of Residence Influence Preference for Rectal Microbicide Dosage Forms Among Young Sexual and Gender Minorities: A Multi-count...
Rebecca Giguere, Iván C Balán, Bryan A Kutner, Seul Ki Choi, Ryan Tingler
AIDS and Behavior. 2024-08-01
Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States.
Albert Y Liu, Holly Gundacker, Barbra Richardson, Beatrice A Chen, Craig Hoesley
Journal of the International AIDS Society. 2024-03-01

Journal Articles

Improvement of Gram-Negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long Experience
Rachael A Lee, Stephen A Moser, Craig J Hoesley, Todd P McCarty, Bernard C Camins, Morgan C Scully, Infection Control and Hospital Epidemiology
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings
Craig J Hoesley, Beatrice A Chen, Jeanna Piper, Clinical Infectious Diseases
Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women
Craig W Hendrix, Robert A Salata, Mark A Marzinke, Craig J Hoesley, Ian McGowan, Clinical Infectious Diseases

Press Mentions

Heersink School of Medicine Launches Distinction in Health EquityNovember 19th, 2024
Researchers Report Trial Results of Rectal Microbicides at HIV R4P Virtual ConferenceFebruary 3rd, 2021
New Options in HIV Prophylaxis Gain Traction Based on Positive Trial Results—Public Health WatchOctober 10th, 2018
Join now to see all